Company Financials

Takeda Pharmaceutical Company Limited Financials

Japanese yen

business Takeda Pharmaceutical Company Limited Company Profile

Main Stock Listing

JPX: 4502

Market Capitalization ¥7.118 Trillion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 232.56
Forward PE 34.44
Price to Sales TTM ¥1.73
Price to Book MRQ ¥1.07
Enterprise to Revenue 2.75
Enterprise to EBITDA 10.67

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2025-03-31
Most Recent Quarter 2025-09-30
Profit Margin 0.75%
Operating Margin 15.29%
Return on Assets TTM 2.09%
Return on Equity TTM 0.47%

Income Statement

Revenue TTM ¥4,417,004,240,896
Revenue per Share TTM ¥2801.81
Quarterly Revenue Growth -5.40%
Gross Profit TTM ¥2,862,113,882,112
EBITDA ¥1,074,195,000,000
Net Income to Common TTM ¥33,074,999,296
Diluted EPS TTM ¥20.79
Quarterly Earnings Growth YoY -5.38%

Balance Sheet

Total Cash MRQ ¥681,485,991,936
Total Cash per Share MRQ ¥431.43
Total Debt MRQ ¥
Total Debt to Equity MRQ 72.79
Current Ratio MRQ 1.37
Book Value per Share MRQ ¥4514.26

Cash Flow

Operating Cash Flow TTM ¥1,199,565,963,264
Levered Free Cash Flow TTM ¥748,482,854,912

4502 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 1,579,594,274
Float Shares 1,578,535,946
Avg 10 Volume 5,109,040
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 0.03%
% Held by Institutions 47.19%

Stock Price Summary

Beta 0.03
Fifty Two Week Low ¥3916.00
Fifty Two Week High ¥4925.00
Fifty Two Week Change 13.92%
Day 50 MA ¥4440.94
Day 200 MA ¥4366.19

Dividends and Splits

Forward Annual Dividend Rate ¥200.00
Forward Annual Dividend Yield 4.14%
Trailing Annual Dividend Rate ¥198.00
Trailing Annual Dividend Yield 4.10%
Payout Ratio 962.57%
Dividend Date
Ex Dividend Date 2026-03-30
Last Split Factor
Last Split Date